Cargando…

Immunotherapy with VGX-3100 (HPV16 and HPV18 plasmids) + INO-9012 (DNA encoding IL-12) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa): interim safety and immunogenicity results

Detalles Bibliográficos
Autores principales: Aggarwal, Charu, Cohen, Roger, Morrow, Matthew P, Bauml, Joshua, Weinstein, Gregory, Boyer, Jean, Shen, Xuefei, Yan, Jian, Goldenberg, Jessica, Nashit, Drishty, Oyola, Sandra, Lee, Jessica, Humeau, Laurent M, Weiner, David B, Yang, Zane, Bagarazzi, Mark L, Weiner, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652471/
http://dx.doi.org/10.1186/2051-1426-3-S2-P426
_version_ 1782401761154170880
author Aggarwal, Charu
Cohen, Roger
Morrow, Matthew P
Bauml, Joshua
Weinstein, Gregory
Boyer, Jean
Shen, Xuefei
Yan, Jian
Goldenberg, Jessica
Nashit, Drishty
Oyola, Sandra
Lee, Jessica
Humeau, Laurent M
Weiner, David B
Yang, Zane
Bagarazzi, Mark L
Weiner, David
author_facet Aggarwal, Charu
Cohen, Roger
Morrow, Matthew P
Bauml, Joshua
Weinstein, Gregory
Boyer, Jean
Shen, Xuefei
Yan, Jian
Goldenberg, Jessica
Nashit, Drishty
Oyola, Sandra
Lee, Jessica
Humeau, Laurent M
Weiner, David B
Yang, Zane
Bagarazzi, Mark L
Weiner, David
author_sort Aggarwal, Charu
collection PubMed
description
format Online
Article
Text
id pubmed-4652471
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46524712015-11-25 Immunotherapy with VGX-3100 (HPV16 and HPV18 plasmids) + INO-9012 (DNA encoding IL-12) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa): interim safety and immunogenicity results Aggarwal, Charu Cohen, Roger Morrow, Matthew P Bauml, Joshua Weinstein, Gregory Boyer, Jean Shen, Xuefei Yan, Jian Goldenberg, Jessica Nashit, Drishty Oyola, Sandra Lee, Jessica Humeau, Laurent M Weiner, David B Yang, Zane Bagarazzi, Mark L Weiner, David J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4652471/ http://dx.doi.org/10.1186/2051-1426-3-S2-P426 Text en Copyright © 2015 Aggarwal et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Aggarwal, Charu
Cohen, Roger
Morrow, Matthew P
Bauml, Joshua
Weinstein, Gregory
Boyer, Jean
Shen, Xuefei
Yan, Jian
Goldenberg, Jessica
Nashit, Drishty
Oyola, Sandra
Lee, Jessica
Humeau, Laurent M
Weiner, David B
Yang, Zane
Bagarazzi, Mark L
Weiner, David
Immunotherapy with VGX-3100 (HPV16 and HPV18 plasmids) + INO-9012 (DNA encoding IL-12) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa): interim safety and immunogenicity results
title Immunotherapy with VGX-3100 (HPV16 and HPV18 plasmids) + INO-9012 (DNA encoding IL-12) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa): interim safety and immunogenicity results
title_full Immunotherapy with VGX-3100 (HPV16 and HPV18 plasmids) + INO-9012 (DNA encoding IL-12) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa): interim safety and immunogenicity results
title_fullStr Immunotherapy with VGX-3100 (HPV16 and HPV18 plasmids) + INO-9012 (DNA encoding IL-12) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa): interim safety and immunogenicity results
title_full_unstemmed Immunotherapy with VGX-3100 (HPV16 and HPV18 plasmids) + INO-9012 (DNA encoding IL-12) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa): interim safety and immunogenicity results
title_short Immunotherapy with VGX-3100 (HPV16 and HPV18 plasmids) + INO-9012 (DNA encoding IL-12) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa): interim safety and immunogenicity results
title_sort immunotherapy with vgx-3100 (hpv16 and hpv18 plasmids) + ino-9012 (dna encoding il-12) in human papillomavirus (hpv) associated head and neck squamous cell carcinoma (hnscca): interim safety and immunogenicity results
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652471/
http://dx.doi.org/10.1186/2051-1426-3-S2-P426
work_keys_str_mv AT aggarwalcharu immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT cohenroger immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT morrowmatthewp immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT baumljoshua immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT weinsteingregory immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT boyerjean immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT shenxuefei immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT yanjian immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT goldenbergjessica immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT nashitdrishty immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT oyolasandra immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT leejessica immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT humeaulaurentm immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT weinerdavidb immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT yangzane immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT bagarazzimarkl immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults
AT weinerdavid immunotherapywithvgx3100hpv16andhpv18plasmidsino9012dnaencodingil12inhumanpapillomavirushpvassociatedheadandnecksquamouscellcarcinomahnsccainterimsafetyandimmunogenicityresults